• Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Jiangxi Boya Bio-Pharmaceutical Co Ltd

+ Add to Watchlist

300294:CH

56.500 CNY 2.170 3.99%

As of 03:00:26 ET on 09/10/2014.

Trading has been halted for 300294:CH

Snapshot for Jiangxi Boya Bio-Pharmaceutical Co Ltd (300294)

Open: 54.290 Day's Range: 53.500 - 56.680 Volume: 1,555,666
Previous Close: 54.330 52wk Range: 39.410 - 56.680 1-Yr Rtn: -

Stock Chart for 300294

No chart data available.
  • 300294:CH 56.500
  • 1D
  • 1M
  • 1Y
54.330
Interactive 300294 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300294

Current P/E Ratio (ttm) 51.8349
Estimated P/E(12/2014) -
Relative P/E vs. SZ399006 0.8997
Earnings Per Share (CNY) (ttm) 1.0900
Est. EPS (CNY) (12/2014) -
Est. PEG Ratio -
Market Cap (M CNY) 4,282.70
Shares Outstanding (M) 75.80
30 Day Average Volume 536,394
Price/Book (mrq) 5.4067
Price/Sale (ttm) 17.6122
Dividend Indicated Gross Yield 0.89%
Cash Dividend (CNY) 0.5000
Dividend Ex-Date 04/03/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300294

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300294

Jiangxi Boya Bio-Pharmaceutical company Limited develops, produces and sells blood product. The Company's main products include human serum albumin, intravenous immunoglobulin (static C) and fibrinogen.

Xu JianxinChairmanLiao XinxiPresident
Liang XiaomingExecutive VPDuan HongzhuanVice President
More Company Profile & Key Executives for 300294

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil